Drug-Delivery Technology Market Report 2025, Size And Growth


The Business Research Company’s 2026 market reports introduce new features such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, all designed to enhance the depth, usability, and strategic value of the insights provided.

What Is the Forecasted Market Size of the Drug-Delivery Technology Market by 2030?
The drug-delivery technology market size has grown rapidly in recent years. It will grow from $54.24 billion in 2025 to $60.27 billion in 2026 at a compound annual growth rate (CAGR) of 11.1%. The growth in the historic period can be attributed to growth in chronic diseases, advancements in pharmaceutical formulations, demand for improved patient compliance, expansion of injectable therapies, innovation in medical devices.

The drug-delivery technology market size is expected to see rapid growth in the next few years. It will grow to $91.41 billion in 2030 at a compound annual growth rate (CAGR) of 11.0%. The growth in the forecast period can be attributed to rise of personalized medicine, increasing biologics and biosimilars, demand for long acting drug delivery, technological advances in implantables, growing home care treatment adoption. Major trends in the forecast period include targeted drug delivery systems, controlled and sustained release formulations, patient centric drug delivery devices, minimally invasive delivery technologies, advanced implantable drug systems.

Claim your free report sample now:
https://www.thebusinessresearchcompany.com/report/drug-delivery-technology-global-market-report

Which Major Growth Factors Are Shaping the Drug-Delivery Technology Market?
The increasing prevalence of chronic diseases is expected to propel the growth of the drug-delivery technology market. Chronic diseases refer to long-term medical conditions that typically progress slowly and require ongoing management. The increasing prevalence of chronic diseases is due to a sedentary lifestyle, which reduces physical activity and contributes to obesity and related health issues. Drug-delivery technology enhances chronic diseases by enabling targeted delivery, controlled release, improved bioavailability, and reduced side effects, ultimately improving treatment effectiveness, patient adherence, and disease management. For instance, in July 2024, according to the Australian Burden of Disease Study 2023 by the Australian Institute of Health and Welfare (AIHW), chronic conditions accounted for 91% of non-fatal burden (years lived with disability) and 78% of fatal burden (years of life lost) in 2023. Therefore, the increasing prevalence of chronic diseases is driving the growth of the drug-delivery technology market.

How Is the Drug-Delivery Technology Market Arranged by Segment Classification?
The drug-delivery technology market covered in this report is segmented –

1) By Type: Oral, Injectable, Topical, Ocular, Nasal, Pulmonary, Transmucosal, Implantable
2) By Application: Cardiovascular Diseases, Oncology, Urology, Diabetes, Central Nervous System (CNS), Ophthalmology, Infections, Other Applications
3) By End User: Hospitals, Clinics, Diagnostic Centers, Home Care Settings, Other End Users

Subsegments:
1) By Oral: Tablets, Capsules, Solutions, Suspensions, Powders, Gels
2) By Injectable: Conventional Injection, Self-Injection, Long-Acting Injection
3) By Topical: Creams, Gels, Lotions, Patches, Ointments
4) By Ocular: Eye Drops, Ointments, Gels, Inserts, Implants
5) By Nasal: Sprays, Drops, Powders, Gels
6) By Pulmonary: Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers
7) By Transmucosal: Buccal, Sublingual, Rectal, Vaginal
8) By Implantable: Biodegradable Implants, Non-Biodegradable Implants, Drug-Eluting Stents

What Are the Major Trends Impacting the Drug-Delivery Technology Market?
Major companies operating in the drug-delivery technology market are focusing on developing innovative products such as prefilled injection devices to enhance patient convenience, improve dosing accuracy, and ensure safer drug administration. A prefilled injection device is a medical device that comes preloaded with a specific dose of medication, eliminating the need for manual drug filling before administration. For instance, in February 2023, Phillips-Medisize LLC, a US-based medical equipment manufacturing company, launched a new disposable pen injector designed for high-volume manufacturing. The injector features a compact and flexible design with customizable dosing and push-button colors to support multiple therapies, including diabetes, fertility, growth hormones, obesity, and osteoporosis. The device aims to help pharmaceutical companies accelerate market entry by offering a cost-effective, ready-to-use solution while reducing commercialization costs and risks.

What Are the Top Companies to Watch in the Drug-Delivery Technology Market?
Major companies operating in the drug-delivery technology market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., AstraZeneca Plc, Novartis AG, GlaxoSmithKline Plc., Cipla Limited, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Vertex Pharmaceuticals Incorporated, Chiesi Farmaceutici S.p.A., United Therapeutics Corporation, Mallinckrodt Pharmaceuticals Plc., Lupin Pharmaceuticals, Inc., Glenmark Pharmaceuticals Limited, Alkermes plc., Halozyme Therapeutics Inc., Sunovion Pharmaceuticals Inc., and Circassia Pharmaceuticals Plc.

Get the full drug-delivery technology market report here:
https://www.thebusinessresearchcompany.com/report/drug-delivery-technology-global-market-report

Which regions are expected to dominate the Drug-Delivery Technology Market during the forecast period?
North America was the largest region in the drug-delivery technology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug-delivery technology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Comments

Post a Comment

Popular posts from this blog

Glycomics or Glycobiology Market Scope, Share Analysis And Growth 2025

Image
Backed by rigorous analysis and deep industry knowledge, this study is designed to support growth and investment decisions in the glycomics or glycobiology market. How Big Is The Glycomics or Glycobiology Market In 2025? The glycomics or glycobiology market size has grown rapidly in recent years. It will grow from $1.85 billion in 2024 to $2.13 billion in 2025 at a compound annual growth rate (CAGR) of 14.9%. The growth in the historic period can be attributed to increased awareness of glycans in biological systems, expansion of glycan-related database and resources, rise in collaborative research initiatives, advancements in glycan synthesis and engineering, glycan biomarker identification. The glycomics or glycobiology market size is expected to see rapid growth in the next few years. It will grow to $3.99 billion in 2029 at a compound annual growth rate (CAGR) of 17.0%. The growth in the forecast period can be attributed to glycan-focused artificial intelligence (AI) and data analy...
Read more

Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Scope, Share Analysis And Growth 2025

Image
Focused on real-world business use, this report highlights what’s changing in the hypertrophic cardiomyopathy (hcm) therapeutics market and what companies should prepare for next. What Is The Projected Market Size & Growth Rate Of The Hypertrophic Cardiomyopathy (HCM) Therapeutics Market? The hypertrophic cardiomyopathy (hcm) therapeutics market size has grown marginally in recent years. It will grow from $1.34 billion in 2024 to $1.37 billion in 2025 at a compound annual growth rate (CAGR) of 1.5%. The growth in the historic period can be attributed to diagnostic advancements, increased disease awareness, drug development and approvals, rising healthcare expenditure, government initiatives and funding. The hypertrophic cardiomyopathy (hcm) therapeutics market size is expected to see steady growth in the next few years. It will grow to $1.56 billion in 2029 at a compound annual growth rate (CAGR) of 3.4%. The growth in the forecast period can be attributed to genetic research and ...
Read more

Smart Crop Monitoring Market Overview, Analysis And Demand By 2034

Image
Aimed at strategic decision-makers, this report explores current opportunities, emerging trends, and market dynamics shaping the smart crop monitoring sector. How Big Is The Smart Crop Monitoring Market In 2025? The smart crop monitoring market size has grown rapidly in recent years. It will grow from $3.47 billion in 2024 to $4.09 billion in 2025 at a compound annual growth rate (CAGR) of 18.0%. The growth in the historic period can be attributed to rising demand for high crop production, increasing global population, significant growth in IOT technology, rising need for sustainable agricultural practices, and increasing regulatory pressures. The smart crop monitoring market size is expected to see rapid growth in the next few years. It will grow to $7.83 billion in 2029 at a compound annual growth rate (CAGR) of 17.6%. The growth in the forecast period can be attributed to the development of automated irrigation systems, the growing trend of farm-to-table movements, an increase in ag...
Read more